Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Risk stratification for cardiac mortality using electrocardiographic markers based on 24-hour Holter recordings: the JANIES-SHD study.

Kinoshita T, Hashimoto K, Yoshioka K, Miwa Y, Yodogawa K, Watanabe E, Nakamura K, Nakagawa M, Nakamura K, Watanabe T, Yusu S, Tachibana M, Nakahara S, Mizumaki K, Ikeda T.

J Cardiol. 2019 Aug 29. pii: S0914-5087(19)30238-2. doi: 10.1016/j.jjcc.2019.07.012. [Epub ahead of print]

PMID:
31474497
2.

Left atrial posterior wall isolation affects complex fractionated atrial electrograms in persistent atrial fibrillation.

Nakatani Y, Sakamoto T, Yamaguchi Y, Tsujino Y, Kataoka N, Nishida K, Mizumaki K, Kinugawa K.

J Arrhythm. 2019 Apr 12;35(3):528-534. doi: 10.1002/joa3.12182. eCollection 2019 Jun.

3.

Impacts of the body size on the left atrial wall thickness and atrial fibrillation recurrence after catheter ablation.

Nakatani Y, Sakamoto T, Yamaguchi Y, Tsujino Y, Kataoka N, Nishida K, Mizumaki K, Kinugawa K.

Heart Vessels. 2019 Aug;34(8):1351-1359. doi: 10.1007/s00380-019-01357-6. Epub 2019 Feb 8.

PMID:
30737525
4.

A case of dermatomyositis with the anti-signal recognition particle antibody that was successfully treated with prednisolone and intravenous immunoglobulin therapy.

Mizumaki K, Maeda S, Ikawa Y, Matsushita T, Takehara K, Hamaguchi Y.

J Dermatol. 2019 Jul;46(7):e251-e253. doi: 10.1111/1346-8138.14790. Epub 2019 Jan 28. No abstract available.

PMID:
30690762
5.

Improvement of Hemodynamic Parameters in Patients With Preserved Left Ventricular Systolic Function by Catheter Ablation of Atrial Fibrillation - A Prospective Study Using Impedance Cardiography.

Nakatani Y, Sakamoto T, Yamaguchi Y, Tsujino Y, Kataoka N, Nishida K, Mizumaki K, Kinugawa K.

Circ J. 2018 Dec 25;83(1):75-83. doi: 10.1253/circj.CJ-18-0911. Epub 2018 Oct 30.

6.

Angiosarcoma-related pneumohemothorax treated with intrapleural paclitaxel administration and pleurodesis with OK-432.

Oishi K, Kitano T, Mizumaki K, Maeda S, Saito D, Yoshida S, Matsumoto I, Takehara K, Hamaguchi Y.

Eur J Dermatol. 2018 Aug 1;28(4):520-521. doi: 10.1684/ejd.2018.3318. No abstract available.

PMID:
30105988
7.

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.

Matsushita T, Kobayashi T, Mizumaki K, Kano M, Sawada T, Tennichi M, Okamura A, Hamaguchi Y, Iwakura Y, Hasegawa M, Fujimoto M, Takehara K.

Sci Adv. 2018 Jul 11;4(7):eaas9944. doi: 10.1126/sciadv.aas9944. eCollection 2018 Jul.

8.

Citrus fruits induced swallow syncope with atrioventricular block or sinus arrest.

Yamaguchi Y, Mizumaki K, Sakamoto T, Nakatani Y, Tsujino Y, Inoue H, Kinugawa K.

J Electrocardiol. 2018 Jul - Aug;51(4):613-616. doi: 10.1016/j.jelectrocard.2018.04.012. Epub 2018 Apr 18.

PMID:
29996999
9.

Vasovagal syncope is associated with poor prognosis in patients with left ventricular dysfunction.

Yamaguchi Y, Mizumaki K, Nishida K, Sakamoto T, Nakatani Y, Kataoka N, Kinugawa K, Inoue H.

Heart Vessels. 2018 Apr;33(4):421-426. doi: 10.1007/s00380-017-1078-0. Epub 2017 Nov 6.

PMID:
29110073
10.

Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease.

Matsushita T, Date M, Kano M, Mizumaki K, Tennichi M, Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K.

Am J Pathol. 2017 Apr;187(4):841-850. doi: 10.1016/j.ajpath.2016.12.016. Epub 2017 Feb 9.

PMID:
28189565
11.

Cycle Length Alternation during Atrioventricular Reentrant Tachycardia: What Is the Mechanism?

Nakatani Y, Mizumaki K, Sakamoto T, Kinugawa K.

Pacing Clin Electrophysiol. 2017 Apr;40(4):434-437. doi: 10.1111/pace.13028. Epub 2017 Mar 3. No abstract available.

PMID:
28150315
12.

Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.

Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi Y, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K.

Br J Dermatol. 2017 Feb;176(2):395-402. doi: 10.1111/bjd.14882. Epub 2017 Jan 19.

PMID:
27452897
13.

Latent pathogenicity of the G38S polymorphism of KCNE1 K+ channel modulator.

Yamaguchi Y, Mizumaki K, Hata Y, Sakamoto T, Nakatani Y, Kataoka N, Ichida F, Inoue H, Nishida N.

Heart Vessels. 2017 Feb;32(2):186-192. doi: 10.1007/s00380-016-0859-1. Epub 2016 Jun 2.

PMID:
27255646
14.

Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.

Kataoka N, Nishida K, Kinoshita K, Sakamoto T, Nakatani Y, Tsujino Y, Mizumaki K, Inoue H, Kinugawa K.

Heart Vessels. 2016 Dec;31(12):2053-2060. Epub 2016 May 28.

PMID:
27236656
15.

Paced QRS fragmentation is associated with spontaneous ventricular fibrillation in patients with Brugada syndrome.

Kataoka N, Mizumaki K, Nakatani Y, Sakamoto T, Yamaguchi Y, Tsujino Y, Nishida K, Inoue H.

Heart Rhythm. 2016 Jul;13(7):1497-503. doi: 10.1016/j.hrthm.2016.03.050. Epub 2016 Mar 24.

PMID:
27018377
16.

Postmortem genetic analysis of sudden unexplained death syndrome under 50 years of age: A next-generation sequencing study.

Hata Y, Kinoshita K, Mizumaki K, Yamaguchi Y, Hirono K, Ichida F, Takasaki A, Mori H, Nishida N.

Heart Rhythm. 2016 Jul;13(7):1544-51. doi: 10.1016/j.hrthm.2016.03.038. Epub 2016 Mar 19.

PMID:
27005929
17.

SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.

Kinoshita K, Takahashi H, Hata Y, Nishide K, Kato M, Fujita H, Yoshida S, Murai K, Mizumaki K, Nishida K, Yamaguchi Y, Kano M, Tabata T, Nishida N.

Heart Rhythm. 2016 May;13(5):1113-1120. doi: 10.1016/j.hrthm.2016.01.008. Epub 2016 Jan 8.

PMID:
26776555
18.

Coefficient of Variation of P-Wave Duration Is a Novel Atrial Heterogeneity Index to Predict Recurrence of Atrial Fibrillation After Catheter Ablation.

Nakatani Y, Sakamoto T, Mizumaki K, Nishida K, Kataoka N, Tsujino Y, Yamaguchi Y, Inoue H.

J Cardiovasc Electrophysiol. 2016 May;27(5):542-8. doi: 10.1111/jce.12920. Epub 2016 Feb 11.

PMID:
26756553
19.

Recurrent syncope in two patients with a sigmoid-shaped interventricular septum and no left ventricular hypertrophy.

Yamaguchi Y, Mizumaki K, Iwamoto J, Nishida K, Sakamoto T, Nakatani Y, Kataoka N, Inoue H.

J Arrhythm. 2015 Dec;31(6):391-4. doi: 10.1016/j.joa.2015.04.006. Epub 2015 May 28.

20.

Differentiation of Slow-Slow Form of AVNRT from AVRT through a Posteroseptal Accessory Pathway by Retrograde P-Wave Amplitude.

Nakatani Y, Mizumaki K, Sakamoto T, Kataoka N, Nishida K, Yamaguchi Y, Tsujino Y, Inoue H.

Pacing Clin Electrophysiol. 2016 Mar;39(3):241-9. doi: 10.1111/pace.12794. Epub 2016 Jan 12.

PMID:
26643980
21.

Abnormal repolarization dynamics in a patient with KCNE1(G38S) who presented with torsades de pointes.

Yamaguchi Y, Mizumaki K, Hata Y, Inoue H.

J Electrocardiol. 2016 Jan-Feb;49(1):94-8. doi: 10.1016/j.jelectrocard.2015.10.002. Epub 2015 Oct 14.

PMID:
26520166
22.

Time-Dependent Changes in QT Dynamics after Initiation and Termination of Paroxysmal Atrial Fibrillation.

Yamaguchi Y, Mizumaki K, Nishida K, Sakamoto T, Kataoka N, Nakatani Y, Inoue H.

Pacing Clin Electrophysiol. 2015 Dec;38(12):1418-24. doi: 10.1111/pace.12746. Epub 2015 Sep 22.

PMID:
26391623
23.

Promising toxicological biomarkers for the diagnosis of liver injury types: Bile acid metabolic profiles and oxidative stress marker as screening tools in drug development.

Masubuchi N, Nishiya T, Imaoka M, Mizumaki K, Okazaki O.

Chem Biol Interact. 2016 Aug 5;255:74-82. doi: 10.1016/j.cbi.2015.09.012. Epub 2015 Sep 11.

PMID:
26365562
24.

Bepridil enhances aprindine-induced prolongation of atrial effective refractory period in a canine atrial rapid pacing model.

Nakatani Y, Sakamoto T, Nishida K, Kataoka N, Yamaguchi Y, Sakabe M, Fujiki A, Mizumaki K, Inoue H.

J Cardiol. 2015 Nov;66(5):445-50. doi: 10.1016/j.jjcc.2015.06.001. Epub 2015 Jul 7.

25.

Glycine/Serine polymorphism at position 38 influences KCNE1 subunit's modulatory actions on rapid and slow delayed rectifier K+ currents.

Yamaguchi Y, Nishide K, Kato M, Hata Y, Mizumaki K, Kinoshita K, Nonobe Y, Tabata T, Sakamoto T, Kataoka N, Nakatani Y, Ichida F, Mori H, Fukurotani K, Inoue H, Nishida N.

Circ J. 2014;78(3):610-8. Epub 2014 Jan 11.

26.

Characterization of a novel mutant KCNQ1 channel subunit lacking a large part of the C-terminal domain.

Kimoto K, Kinoshita K, Yokoyama T, Hata Y, Komatsu T, Tsushima E, Nishide K, Yamaguchi Y, Mizumaki K, Tabata T, Inoue H, Nishida N, Fukurotani K.

Biochem Biophys Res Commun. 2013 Oct 18;440(2):283-8. doi: 10.1016/j.bbrc.2013.09.075. Epub 2013 Sep 23.

PMID:
24070608
27.

Electrophysiological and anatomical differences of the slow pathway between the fast-slow form and slow-slow form of atrioventricular nodal reentrant tachycardia.

Nakatani Y, Mizumaki K, Nishida K, Sakamoto T, Yamaguchi Y, Kataoka N, Sakabe M, Fujiki A, Inoue H.

Europace. 2014 Apr;16(4):551-7. doi: 10.1093/europace/eut253. Epub 2013 Aug 20.

PMID:
23964065
28.

Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.

Nakatani Y, Nishida K, Sakabe M, Kataoka N, Sakamoto T, Yamaguchi Y, Iwamoto J, Mizumaki K, Fujiki A, Inoue H.

J Am Coll Cardiol. 2013 Feb 5;61(5):582-8. doi: 10.1016/j.jacc.2012.11.014. Epub 2012 Dec 26. Erratum in: J Am Coll Cardiol. 2013 Dec 10;62(23):2260.

29.

Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.

Sakabe M, Fujiki A, Sakamoto T, Nakatani Y, Mizumaki K, Inoue H.

J Cardiovasc Electrophysiol. 2012 Oct;23(10):1130-5. doi: 10.1111/j.1540-8167.2012.02356.x. Epub 2012 May 15.

PMID:
22587612
30.

Anticoagulation control quality affects the D-dimer levels of atrial fibrillation patients.

Nakatani Y, Mizumaki K, Nishida K, Hirai T, Sakabe M, Oda Y, Joho S, Fujiki A, Nozawa T, Inoue H.

Circ J. 2012;76(2):317-21. Epub 2011 Dec 17.

31.

Vagal activity modulates spontaneous augmentation of J-wave elevation in patients with idiopathic ventricular fibrillation.

Mizumaki K, Nishida K, Iwamoto J, Nakatani Y, Yamaguchi Y, Sakamoto T, Tsuneda T, Kataoka N, Inoue H.

Heart Rhythm. 2012 Feb;9(2):249-55. doi: 10.1016/j.hrthm.2011.09.055. Epub 2011 Sep 20.

PMID:
21939630
32.

Early repolarization in Wolff-Parkinson-White syndrome: prevalence and clinical significance.

Mizumaki K, Nishida K, Iwamoto J, Nakatani Y, Yamaguchi Y, Sakamoto T, Tsuneda T, Inoue H, Sakabe M, Fujiki A.

Europace. 2011 Aug;13(8):1195-200. doi: 10.1093/europace/eur144. Epub 2011 May 11.

PMID:
21565837
33.

Atrioventricular node ablation and pacemaker implantation for recurrent syncope in a patient with postural tachycardia syndrome (POTS).

Nakatani Y, Mizumaki K, Nishida K, Inoue H.

J Cardiovasc Electrophysiol. 2011 Nov;22(11):1284-7. doi: 10.1111/j.1540-8167.2011.02078.x. Epub 2011 May 3.

PMID:
21539639
34.

Narrow QRS ventricular tachycardia from the posterior mitral annulus without involvement of the His-Purkinje system in a patient with prior inferior myocardial infarction.

Sakamoto T, Fujiki A, Nakatani Y, Sakabe M, Mizumaki K, Inoue H.

Heart Vessels. 2010 Mar;25(2):170-3. doi: 10.1007/s00380-009-1180-z. Epub 2010 Mar 26.

PMID:
20339980
35.

d,l-Sotalol reverses abbreviated atrial refractoriness and prevents promotion of atrial fibrillation in a canine model with left ventricular dysfunction induced by atrial tachypacing.

Sakamoto T, Fujiki A, Nakatani Y, Sakabe M, Mizumaki K, Hashimoto N, Inoue H.

Circ J. 2009 Oct;73(10):1820-8. Epub 2009 Aug 27.

36.

Junctional rhythm associated with ventriculoatrial block during slow pathway ablation in atypical atrioventricular nodal re-entrant tachycardia.

Fujiki A, Sakamoto T, Sakabe M, Tsuneda T, Sugao M, Nakatani Y, Mizumaki K, Inoue H.

Europace. 2008 Aug;10(8):982-7. doi: 10.1093/europace/eun151. Epub 2008 Jun 9.

PMID:
18541619
37.

Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.

Fujiki A, Sakamoto T, Nishida K, Mizumaki K, Inoue H.

J Cardiovasc Pharmacol. 2007 Sep;50(3):264-6.

PMID:
17878753
38.

Postprandial augmentation of bradycardia-dependent ST elevation in patients with Brugada syndrome.

Mizumaki K, Fujiki A, Nishida K, Iwamoto J, Sakamoto T, Sakabe M, Tsuneda T, Sugao M, Inoue H.

J Cardiovasc Electrophysiol. 2007 Aug;18(8):839-44. Epub 2007 Jun 6.

PMID:
17553072
39.

Bepridil reverses atrial electrical remodeling and L-type calcium channel downregulation in a canine model of persistent atrial tachycardia.

Nishida K, Fujiki A, Sakamoto T, Iwamoto J, Mizumaki K, Hashimoto N, Inoue H.

J Cardiovasc Electrophysiol. 2007 Jul;18(7):765-72. Epub 2007 Apr 30.

PMID:
17472715
40.

Pharmacological cardioversion of persistent atrial fibrillation with and without a history of drug-resistant paroxysmal atrial fibrillation.

Fujiki A, Sakamoto T, Iwamoto J, Nishida K, Nagasawa H, Mizumaki K, Inoue H.

Circ J. 2006 Sep;70(9):1138-41.

41.

Double potentials at successful catheter ablation site of left-sided retrograde accessory pathway: mitral isthmus block or conduction through coronary sinus musculature.

Fujiki A, Usuda K, Mizumaki K, Abe T, Iwamoto J, Ishikawa T, Inoue H.

Int J Cardiol. 2007 Apr 12;117(1):90-6. Epub 2006 Jul 26.

PMID:
16872697
42.

Bradycardia-dependent ECG changes in Brugada syndrome.

Mizumaki K, Fujiki A, Nishida K, Sakabe M, Tsuneda T, Sugao M, Iwamoto J, Nagasawa H, Inoue H.

Circ J. 2006 Jul;70(7):896-901.

43.

Enalapril preserves sinus node function in a canine atrial fibrillation model induced by rapid atrial pacing.

Sakabe M, Fujiki A, Nishida K, Sugao M, Nagasawa H, Tsuneda T, Mizumaki K, Inoue H.

J Cardiovasc Electrophysiol. 2005 Nov;16(11):1209-14.

PMID:
16302906
44.

New quantitative methods for evaluation of dynamic changes in QT interval on 24 hour Holter ECG recordings: QT interval in idiopathic ventricular fibrillation and long QT syndrome.

Sugao M, Fujiki A, Sakabe M, Nishida K, Tsuneda T, Iwamoto J, Mizumaki K, Inoue H.

Heart. 2006 Feb;92(2):201-7. Epub 2005 May 20.

45.

Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide.

Sugao M, Fujiki A, Nishida K, Sakabe M, Tsuneda T, Iwamoto J, Mizumaki K, Inoue H.

J Cardiovasc Pharmacol. 2005 Jun;45(6):545-9.

PMID:
15897781
46.

Dynamic changes in the QT-R-R relationship during head-up tilt test in patients with vasovagal syncope.

Mizumaki K, Fujiki A, Sakabe M, Nishida K, Sugao M, Tsuneda T, Nagasawa H, Inoue H.

Ann Noninvasive Electrocardiol. 2005 Jan;10(1):16-24.

PMID:
15649233
47.
48.

Nonlinear mixed effects model analysis of the pharmacokinetics of metoprolol in routinely treated Japanese patients.

Taguchi M, Nozawa T, Mizumaki K, Inoue H, Tahara K, Takesono C, Hashimoto Y.

Biol Pharm Bull. 2004 Oct;27(10):1642-8.

49.

Canine model of Brugada syndrome using regional epicardial cooling of the right ventricular outflow tract.

Nishida K, Fujiki A, Mizumaki K, Sakabe M, Sugao M, Tsuneda T, Inoue H.

J Cardiovasc Electrophysiol. 2004 Aug;15(8):936-41.

PMID:
15333091

Supplemental Content

Loading ...
Support Center